Newbridge Financial Services Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$168 Hold
12
﹤0.01% 1134
2025
Q4
$135 Hold
12
﹤0.01% 1144
2025
Q3
$139 Hold
12
﹤0.01% 1254
2025
Q2
$147 Hold
12
﹤0.01% 1273
2025
Q1
$172 Sell
12
-49
-80% -$765 ﹤0.01% 1001
2024
Q4
$971 Buy
61
+49
+408% +$970 ﹤0.01% 1021
2024
Q3
$288 Hold
12
﹤0.01% 625
2024
Q2
$239 Hold
12
﹤0.01% 1040
2024
Q1
$239 Hold
12
﹤0.01% 1118
2023
Q4
$269 Hold
12
﹤0.01% 1069
2023
Q3
$243 Hold
12
﹤0.01% 1234
2023
Q2
$307 Hold
12
﹤0.01% 1278
2023
Q1
$357 Hold
12
﹤0.01% 1336
2022
Q4
$325 Hold
12
﹤0.01% 1374
2022
Q3
$0 Hold
12
﹤0.01% 1381
2022
Q2
$0 Hold
12
﹤0.01% 1361
2022
Q1
$0 Hold
12
﹤0.01% 1436
2021
Q4
$0 Hold
12
﹤0.01% 1413
2021
Q3
$1K Hold
12
﹤0.01% 1223
2021
Q2
$0 Hold
12
﹤0.01% 1431
2021
Q1
$1K Hold
12
﹤0.01% 1231
2020
Q4
$1K Hold
12
﹤0.01% 1004
2020
Q3
$0 Buy
+12
New +$383 ﹤0.01% 1028

Other funds holding AVNS

Newbridge Financial Services Group's AVNS Position: Q1 2026 in Review

Newbridge Financial Services Group held its Avanos Medical (AVNS) position steady in Q1 2026 at 12 shares worth $168. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

Newbridge Financial Services Group first reported a position in AVNS in Q3 2020 and has held it in 23 quarters since. The position peaked at $1K in Q3 2021. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Newbridge Financial Services Group held 12 shares of Avanos Medical worth $168 as of Q1 2026.
  • Newbridge Financial Services Group left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #1134 holding.
  • Newbridge Financial Services Group first reported a position in Avanos Medical in Q3 2020 and has held it in 23 quarters since.
  • Newbridge Financial Services Group's Avanos Medical position peaked at $1K in Q3 2021.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.